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Abstract
Objectives/Hypothesis—To create a novel model for development of a tissue-engineered
salivary gland from human salivary gland cells that retain progenitor cell markers useful for
treatment of radiation-induced xerostomia.
Study Design—A 3D hyaluronic acid (HA)-based hydrogel scaffold was used to encapsulate
primary human salivary gland cells and to obtain organized acini-like spheroids. Hydrogels were
implanted into rat models and cell viability and receptor expression were evaluated.
Methods—A parotid gland surgical resection model for xenografting was developed. Salivary
cells loaded in HA hydrogels formed spheroids in vitro and were implanted in the ¾ resected
parotid bed of athymic rats. Implants were removed after one week and analyzed for spheroid
viability and phenotype retention.
Results—Spheroids in 3D stained positive for HA receptors CD168/RHAMM and CD44, which
is also a progenitor cell marker. The parotid gland ¾ resection model was well-tolerated by rodent
hosts and the salivary cell/hydrogel scaffolds were adherent to the remaining parotid gland, with
no obvious signs of inflammation. A majority of human cells in the extracted hydrogels
demonstrated robust expression of CD44.
Conclusions—A 3D HA-based hydrogel scaffold that supported long-term culture of salivary
gland cells into organized spheroids was established. An in vivo salivary gland resection model
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was developed that allowed for integration of the 3D HA hydrogel scaffold with the existing
glandular parenchyma. The expression of CD44 among salivary cultures may partially explain
their regenerative potential and the expression of CD168/RHAMM along with CD44 may aid the
development of these 3D spheroids into regenerated salivary glands.
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Bioartificial Organ; 3-D Cell Culture; Salivary Gland; Tissue Engineering; Regeneration;
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Introduction
Treatment for xerostomia and its sequelae post radiation therapy for upper respiratory tract
malignancy are presently inadequate. Quality of life can be potentially improved with the
generation of a functional, tissue-engineered salivary gland. Tissue engineers continue to
accumulate clinical successes through implementation, either in full or in part, of the classic
cells-in-scaffolds model. Components of this model often are used separately. For example,
textured hip implants and porous cardiac stents represent open “scaffolds” for ingrowth of
osteogenic precursors, or overgrowth of endothelial cells, respectively. The clinical
successes of combined cell-scaffold therapies represent the closest approximation to native
tissue structures. Two recent examples relevant to this study are found in the trachea, where
multiple cell types and scaffolds were implemented in clinical trials, and the pioneering
work in the tissue engineered urinary bladder.1,2 These represent some of the limited
examples of tissue-engineered constructs using multiple combined cell types, in particular,
those of epithelial and mesenchymal lineages.
3D in vitro systems enable extensive testing of biological pathways under a controlled
laboratory environment, and provide greater fidelity to the in vivo condition than traditional
2D cell culture. Despite these improvements, mechanisms such as angiogenesis,
neurogenesis, and inflammation response can only be effectively observed in an in vivo
model. For our goal of restoring salivary function after radiation-induced xerostomia, an
appropriate animal model must reflect the observed loss of acinar cell function within the
salivary bed. Suitable facilities for replicating radiation damage require appropriately sized
machinery and extensive regulatory protocols and training. Such facilities are costly and are
not ubiquitous across U.S. research institutions.
We have reported the use of soft hyaluronic acid (HA) hydrogels as biocompatible
substrates for salivary gland tissue engineering.3,4 HA is a ubiquitous extracellular matrix
(ECM) polysaccharide found throughout the body. In our current effort toward salivary
gland regeneration, we source healthy human parotid gland tissue, and extract acinar-like
cells by enzymatic digestion providing salivary acinar-enriched cell cultures.3–5 HA
potentially serves as an optimal material for salivary gland regeneration, as it promotes
strong cell-cell junction formation, but can be recognized and potentially remodeled by
cells. HA offers utility as a biomaterial, as it can be synthesized as a high molecular weight
raw material by bacteria and then chemically functionalized with reactive sites to enable the
formation of covalent hydrogel networks.6 Multiple biocompatible crosslinking chemistries
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have been described, including aldehyde-hydrazide systems, and the thiol-acrylate system,
which we employ here for encapsulation of cultured human salivary cells in 3D hydrogel
scaffolds.
Tissue engineering of glandular tissues requires several essential components: 1) primary
cells that retain biomarkers typical of the native gland, 2) extracellular matrix proteins that
can orchestrate the differentiation of primary/progenitor-like cells into functional structures,
and 3) a bio-compatible and bio-degradable scaffold that can hold these components
together and re-create the microenvironment found in native glandular tissue. We have
shown that isolated human salivary acinar-like cells will self-assemble into spheroids when
cultured in 3D HA hydrogels. These cells retain cellular structures such as tight junction
proteins ZO-1, CL-1, E-cadherin, and focal adhesion kinase (FAK). They also express the
water channel protein, aquaporin-5 and functionally respond with production and secretion
of the salivary enzyme α-amylase and intracellular calcium activation in response to the
neurotransmitter agonists.3–5
This manuscript describes a first of its kind in vivo model with cultured human salivary
gland cells that can be potentially adapted to other tissue-engineered exocrine glands
including lacrimal and mammary gland, as well as pancreas. We demonstrate resection of
three-fourths of the parotid gland in a rat model that enables us to assess incorporation of the
hydrogel scaffold into the existing salivary bed. We hypothesize that this in vivo surgical
model will promote human salivary spheroid retention and phenotype preservation, and
integrate into surrounding tissue with minimal inflammation.
We describe salivary acinar-like cell encapsulation in 3D HA-based hydrogel scaffolds, and
characterize the cells’ expression of the HA receptors CD44 and RHAMM. These two cell
surface markers found on salivary cultured cells bind to HA. HA forms the basic unit of our
3D HA-based hydrogel scaffold that allows cultured salivary gland acinar-like cells to grow
in 3D. CD44 expression has previously been reported in acinar, myoepithelial, and basal
duct cells of human salivary gland tissue.7,8 It has also been proposed that CD44 is involved
in regulating the growth and renewal of normal salivary gland tissue.7 CD44 also is posited
as a stem cell marker. We hypothesize that primary salivary acinar-like cells that organize
into acini-like spheroids in vitro will express CD44 and RHAMM, and retain these
morphologic and phenotypic characteristics after in vivo implantation.
Materials and Methods
Tissue and Cell Culture
An Institutional Review Board (IRB-Christiana Care Health Systems) approved tissue
procurement protocol is in place for obtaining human salivary tissue from patients
undergoing routine salivary gland surgery. Parotid gland tissue was procured from patients
between the ages of 40 – 60 years. Human salivary gland acinar-like secretory cells were
obtained via tissue explant outgrowths and tissue dissociation techniques.3–5 Ductal cell
cultures were not used in this study. To dissociate the tissue, the specimen was minced into
small pieces and suspended in Hepato-STIM medium (BD Biosciences Discovery Labware).
Tissue explants were seeded in six well plates (BD Falcon™) and growth media was not
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exchanged for 7 days so that they could adhere to the plates and cells could migrate out of
the explants. Cells were passaged with 0.05% (w/v) trypsin EDTA (Invitrogen). Trypsin
soybean inhibitor (0.05 mg/mL, Sigma) was used to inactivate trypsin.
3D Hydrogel Preparation
An HA-based hydrogel system (Hystem™, BioTime, Inc.) was utilized for the encapsulation
of salivary acinar-like cells in 3D. 1 × 105 cells were seeded in every 150μL hydrogel.
Hydrogels were prepared according to the kit directions.3 Hydrogels were prepared in 12mm
cell culture inserts (Millipore) placed in 24-well plates (Corning®). Growth medium was
added both to the outside chamber of the culture insert and on top of the hydrogel.
Immunofluorescence
Primary antibodies used were polyclonal CD44 (Novus Biologicals) and CD168/RHAMM
(Abcam). Secondary antibodies included Alexa Fluor 488 and Alexa Fluor 568 (Life
Technologies) against mouse or rabbit IgG. Draq5 (Biostatus) was used for staining nuclei.
A Zeiss 510 NLO LSM confocal microscope was used to image all stained samples.
3D HA hydrogel scaffolds (cultured in vitro and in vivo) were stained as follows:3
Hydrogels were fixed with either 4% (w/v) paraformaldehyde or cold 100% methanol for 15
min at room temperature. Hydrogels were washed, rehydrated with 1 X PBS for 5 min, and
permeabilized with 0.2% (v/v) Triton X-100 for 15 min. Hydrogels were washed twice with
1 X PBS and blocked overnight at 4°C in 3% (w/v) BSA in PBS. Primary antibodies were
prepared in blocking solution and hydrogels were incubated in the antibody solution for 75
min at 37°C. Samples were washed thrice, 10 min each time, with 1 X PBS. Hydrogels were
incubated in secondary antibody for 60 min at 37°C. Draq5 was added immediately after the
secondary antibody and was incubated for 10 min at 37°C. Hydrogels were washed again
thrice, for 10 min each. Gel Mount (Electron Microscopy Systems) was added on top of the
hydrogels prior to imaging.
Resection Model
An Institutional Animal Care and Use Committee (IACUC) approved protocol was used for
all animal studies. Immunocompetent male, 3 month old, Sprague-Dawley rats (Harlan
Laboratories), were used for the implantation of cell-free HA hydrogels while male, 3 month
old immunocompromised (hooded T-cell deficient athymic) rats were used for implantation
of human salivary cell-loaded HA hydrogels. The animals were anesthetized using a
combined ketamine/xylazine intramuscular injection (ketamine: 50–100mg/kg; xylazine: 5–
10mg/kg) anesthesia. Once under anesthesia, the facial area of the rat was shaved. A surgical
scrub was used to wipe and disinfect the area. A #11 surgical blade was used to make a 10–
15mm incision caudal to the auricle (around 2–3 mm inferior to the ear). Fine scissors were
used to dissect through the layers of the skin until the parotid gland was visible. A portion of
the parotid gland was elevated using forceps and then resected using fine scissors, leaving
~1/4 of the gland intact. A hydrogel implant was then placed in the parotid bed and the
wound was closed using a 4–0 Vicryl™ suture. Sprague-Dawley rats received an HA
hydrogel with no encapsulated cells, while athymic rats received an HA hydrogel which had
been seeded with human salivary cells, and cultured in vitro for 22 days prior to
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implantation. Surgical glue was applied. The rats were sacrificed after one-week. The
hydrogels were removed, fixed, and stained as described above for further analysis.
Results
Acini-like spheroids express HA receptors in 3D hydrogels
Salivary acinar-like cells seeded in 3D HA hydrogel scaffolds self-assembled into 3D
aggregates within 72 hours. These aggregates become organized spheroids within 6 – 8 days
of culture. Spheroids growing in 3D HA hydrogels for 22 days expressed CD44 and CD168/
RHAMM on their cell membranes (Figure 1 A–C). Salivary spheroids maintained viability
in culture for over 150 days (Figure 1 D–I). CD44 and CD168/RHAMM were retained by
these larger spheroids over time and were expressed by cells throughout the spheroid as seen
in the representative Z-stack slices ranging from 6.55 – 11.22 μm (Figure 1 D–I).
Parotid gland surgical resection and hydrogel implantation in a rat model
A parotid gland surgical resection model was developed to simulate acinar-cell loss in
immunocompetent Sprague Dawley rats. No excess bleeding was observed during the ¾
resection of the rat parotid gland (Figure 2). The implant was well tolerated and the wound
healed completely in about a week (Figure 2F). No obvious signs of inflammation were
seen. Adhesions were observed between the hydrogel implant and the remnant parotid
tissue. The acellular HA hydrogels showed vascularization by the host within one-week due
to the highly vascularized nature of the parotid bed (Figure 2G). Hydrogels maintained their
structure and degraded slowly over 3 weeks (data not shown).
Retention of spheroid structure and biomarker expression after one-week implantation in
vivo
Human salivary cell-seeded hydrogels implanted in our athymic rat surgical resection model
maintained viability of the encapsulated spheroids. The implanted hydrogel scaffold
remained intact in the salivary bed and adhered to the resected gland within a week of
implantation (Figure 3A). A clean, intact hydrogel implant is seen in vivo (Figure 3B).
Figure 3C shows the site of implantation and remnant parotid tissue after removal of the
hydrogel scaffold from Figure 3B. Salivary spheroids encapsulated in the hydrogel scaffold
retained expression of CD44 and RHAMM for a week in vivo (Figure 3D). The same
peripheral cell membrane staining observed in the in vitro condition was identified in the
explanted in vivo samples, and the cells retained similar spheroid morphology.
Discussion
Our previous work has described the self-assembly of acini-like spheroids and expression of
essential salivary biomarkers in 3D HA hydrogel scaffolds including tight junction and
adherens junction proteins, salivary enzyme, α-amylase and sympathetic and
parasympathetic neurotransmitter receptors.3 Here we report the expression of HA receptors
CD168/RHAMM and CD44 among our salivary spheroid cultures in 3D HA hydrogel
scaffolds. Additionally, we report a parotid gland resection model that simulates acinar cell
loss and promotes survival of cultured salivary acinar-like cells and, retention of HA
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receptors in vivo. Our primary human salivary acinar-like cells have demonstrated robust
expansion and growth capabilities, with little evidence of senescence. Their near-universal
expression of CD44 would support its status as a stem cell marker. We have previously
reported that our salivary spheroids survive, retain their morphology and biomarkers,
including the salivary enzyme α-amylase, for over three-weeks in vivo when implanted in
the back of athymic rats.3 In this report, we moved to a more relevant site of implantation,
the parotid bed.
To surgically simulate acinar cell loss, a parotid gland resection model was developed in
which, three-fourths of the left parotid gland of a rat was resected. The right parotid was left
intact to minimize detriment to the animal from the reduction in saliva. Additionally, the
right parotid can also act as a control. This method allows us to implant our test constructs in
a physiologically relevant tissue bed, assess their outcome, and cause minimal harm to the
host during the experiments. We observed signs of vascularization within one week in the
highly vascularized parotid bed. Integration of the hydrogels adjacent to the remaining one-
fourth of the left parotid gland was observed, with minimal inflammation in either Sprague-
Dawley or athymic rats. Salivary spheroids remained viable for extended periods of time
and continued to express HA receptors. Our HA gels remain stable long enough to support
growth and integration of implants with native tissues. These observations, along with the
retention of implanted cell morphology and phenotype expression, continue to support the
feasibility of our model for salivary gland regeneration. Continued development of this
model will include investigations of gel degradation properties, vascularization/innervation
of the implant, incorporating complex extracellular matrix proteins, cells, growth factors and
eventual comparison with in vivo models of acinar damage from radiation therapy. Studies
using human submandibular gland cell cultures to add to our parotid gland cell cultures used
in this report have been initiated.
HA is a ubiquitously expressed polysaccharide in the extracellular matrix of vertebrate
tissues that, through its interactions with ECM proteins, has been shown to contribute to the
structural and mechanical integrity of the underlying connective tissue.6 HA has been shown
to influence cell behavior through its direct interaction with the proteoglycan CD44 which
triggers signal transduction pathways that regulate cell migration, proliferation, and
differentiation.6 The interaction of HA with CD44 has also been associated with activation
of Rac1, a small GTP-binding protein, reorientation of cells as well as remodeling of actin
cytoskeleton.9 CD44 and RHAMM signaling may therefore be involved in formation and
retention of salivary spheroid structures in HA hydrogels.
During early wound repair processes in adults, excess polymeric HA is produced by stromal
cells and functions to slow pathogen invasion and preserve growth factor stability.10
Subsequently, the HA barrier is gradually degraded and replaced by collagen deposition and
initiation of a fibrotic repair response. Conversely, in regeneration (such as observed during
early development), fibrosis is delayed in favor of the extended retention of HA.11 These
two mechanisms can be further identified by cell-ECM interactions during each phase
through expression of ECM binding receptors on the cell surface. Integrins serve as the
primary cell-ECM interface to collagen substrates during a fibrotic repair, and their closest
analogues for HA substrates include the CD44 and CD168 (RHAMM) receptors.12,13 In our
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model of salivary gland regeneration within HA hydrogels, these two receptors are
particularly relevant, as they represent an interface between cells and their surrounding
matrix.7
Most recently, the investigation of these HA binding proteins in the context of the salivary
gland has focused on their observed upregulation around tumor sites.14–16 These proteins are
also observed in cancers of the breast and other tissues, suggesting a role in aberrant,
unregulated wound repair. Therefore, the apparent dual nature of CD44 and RHAMM – as
markers of healthy regeneration or as markers of unrestricted aberrant neoplasia – reflects
the same general function: an interface between the cell and its surrounding matrix.
Conclusions
Here we report a 3D HA-hydrogel culture system capable of supporting long-term growth,
structure retention and HA receptor expression. An in vivo parotid gland resection model
was developed to mimic acinar-cell loss and to allow for integration of a salivary cell-laden
hydrogel scaffold with native glandular tissue. We predict that the expression of the
progenitor cell marker CD44 in salivary spheroid cultures may atleast partially explain their
regenerative potential. Future studies using this scaffold will allow increased complexity
through addition of cytokines and other ECM components to direct the response of both host
and donor cells. Our envisioned treatment plan will utilize the patient’s native salivary cells
harvested before they are damaged by radiation, then integrated ex vivo with an HA
hydrogel scaffold. By supplying the appropriate growth factors and extracellular cues to the
harvested cells, as they would present during normal tissue genesis, a fully functional
salivary gland could be formed and implanted in the patient once the radiation treatment is
complete.
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Fig 1. Expression of CD44 and RHAMM among salivary spheroids in 3D HA hydrogels
Salivary spheroids cultured for 22 days show expression of CD44 (red) in (A) and CD168/
RHAMM (green) in (B). A merged image is seen in (C). (D)–(I) show Z-stack optical slices
ranging from 6.55 – 11.22 μm with expression of CD44 (red) and CD168/RHAMM (green)
observed among all optical slices of the spheroids growing in culture for 150 days.
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Fig 2. Development of a novel parotid gland resection model to simulate acinar cell-loss
A 15mm incision caudal to the auricle (A) was made to access the parotid gland seen in
panel (B). Three-fourths of the gland was resected (C) and the hydrogel implant was inserted
into the cavity (D). The wound was sutured and surgical glue was applied (E). Panel (F)
shows the site of implantation at one week with no signs of inflammation. The partially
vascularized hydrogel implant and the resected gland (G) were observed at one week post-
implantation.
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Fig 3. Implantation of a salivary cell-laden hydrogel scaffold to ensure retention of spheroid
structure and biomarker expression in vivo
(A) Integration of a salivary acinar-like cell-loaded hydrogel implant with the resected
parotid gland after one week in vivo. Yellow arrow shows the site of integration. White
arrow points to the hydrogel. (B) An intact HA hydrogel scaffold is demonstrated (white
circle). (C) Site of implantation after removal of implant is seen in panel (B). Boxed area
shows the resected parotid gland. Black arrow points to the masseter muscle. Retention of
CD44 staining (D, red), CD168/RHAMM staining (E, green) and merged image is seen in
(F).
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